Michael PORTS

Person

Seattle, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Immunotherapy methods and compositions involving tryptophan metabol...
- Patent number 11,896,615
- Issue date Feb 13, 2024
- Juno Therapeutics, Inc.
- Michael Ports
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for use of therapeutic T cells in combinat...
- Patent number 11,590,167
- Issue date Feb 28, 2023
- Juno Therapeutic, Inc.
- Michael Ports
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION OF A CAR T CELL THERAPY AND AN IMMUNOMODULATORY COMPOUN...
- Publication number 20240197871
- Publication date Jun 20, 2024
- Juno Therapeutics, Inc.
- Nikolaus Sebastian TREDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINAT...
- Publication number 20240016840
- Publication date Jan 18, 2024
- Juno Therapeutics, Inc.
- Michael Ports
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF BCMA-DIRECTED T CELL THERAPY AND AN IMMUNOMODULATORY...
- Publication number 20230165872
- Publication date Jun 1, 2023
- Juno Therapeutics, Inc.
- Michael PORTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF A T CELL THERAPY AND (S)-3-[4-(4-MORPHOLIN-4-YLMETHY...
- Publication number 20220401483
- Publication date Dec 22, 2022
- Juno Therapeutics, Inc.
- Michael PORTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A CELL-MEDIATED CYTOTOXIC THERAPY AND AN INH...
- Publication number 20220249637
- Publication date Aug 11, 2022
- Juno Therapeutics, Inc.
- Michael PORTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMBINATIONS FOR TREATMENT AND T CELL MODULATION
- Publication number 20220008477
- Publication date Jan 13, 2022
- Juno Therapeutics, Inc.
- Jens HASSKARL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF A CELL THERAPY AND AN IMMUNOMODULATORY COMPOUND
- Publication number 20200078404
- Publication date Mar 12, 2020
- Juno Therapeutics, Inc.
- Michael PORTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPY METHODS AND COMPOSITIONS INVOLVING TRYPTOPHAN METABOL...
- Publication number 20200054673
- Publication date Feb 20, 2020
- Juno Therapeutics, Inc.
- Michael PORTS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINAT...
- Publication number 20190328786
- Publication date Oct 31, 2019
- Juno Therapeutic, Inc.
- Michael PORTS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF A T CELL-BASED THERAPY AND A BTK INHIBITOR
- Publication number 20190298772
- Publication date Oct 3, 2019
- Juno Therapeutics, Inc.
- Michael PORTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Michael PORTS

Person

Patents Grantslast 30 patents

Immunotherapy methods and compositions involving tryptophan metabol...

Methods and compositions for use of therapeutic T cells in combinat...

Patents Applicationslast 30 patents

COMBINATION OF A CAR T CELL THERAPY AND AN IMMUNOMODULATORY COMPOUN...

METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINAT...

COMBINATION OF BCMA-DIRECTED T CELL THERAPY AND AN IMMUNOMODULATORY...

COMBINATION OF A T CELL THERAPY AND (S)-3-[4-(4-MORPHOLIN-4-YLMETHY...

COMBINATION THERAPY OF A CELL-MEDIATED CYTOTOXIC THERAPY AND AN INH...

METHODS AND COMBINATIONS FOR TREATMENT AND T CELL MODULATION

COMBINATION OF A CELL THERAPY AND AN IMMUNOMODULATORY COMPOUND

IMMUNOTHERAPY METHODS AND COMPOSITIONS INVOLVING TRYPTOPHAN METABOL...

METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINAT...

COMBINATION THERAPY OF A T CELL-BASED THERAPY AND A BTK INHIBITOR